Mutschler 2012 Abstract Bioblast: Difference between revisions
No edit summary |
Bader Helga (talk | contribs) No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 15: | Line 15: | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
|organism=Human | |organism=Human | ||
|injuries=Mitochondrial disease | |||
|journal=Mitochondr Physiol Network | |journal=Mitochondr Physiol Network | ||
|articletype=Abstract | |articletype=Abstract | ||
| Line 28: | Line 28: | ||
== Help == | == Help == | ||
* [[ | * [[MitoPedia: Terms and abbreviations]] | ||
Latest revision as of 15:35, 23 February 2015
| Mutschler R (2012) Regenerative mitochondrial medicine – from basic research to medical practice. Mitochondr Physiol Network 17.12. |
Link: MiPNet17.12 Bioblast 2012 - Open Access
Mutschler R (2012)
Event: Bioblast 2012
Where mitochondria are damaged and energy production is reduced, there are resulting deseases and malfunctioning of tissue and organs. The most important tool in regenerative mitochondrial medicine during treatment of secondary mitochondropathia is to avoid the causing noxes. Further, very important parts in regenerative mitochondrial medicine are orthomolecular therapy, nutritional therapy and microbiological intestinal therapy as well as treating the milieu. The latest novelty is focussing on the amygdala for neurostress reduction.
• Keywords: Regenerative mitochondrial medicine
Labels:
Stress:Mitochondrial disease Organism: Human
Affiliations and author contributions
CFI Centrum für Integrative Medizin Speyer, KompetenzCentrum für Ganzheitliche Gesundheit und Gesundheitsförderung, Speyer, Germany; Email: [email protected]
